Howard Capital Management Inc. Purchases New Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Howard Capital Management Inc. purchased a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 526 shares of the biotechnology company’s stock, valued at approximately $313,000.

Several other large investors have also recently bought and sold shares of the business. Geode Capital Management LLC grew its stake in Axon Enterprise by 2.0% in the third quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock valued at $710,103,000 after purchasing an additional 35,320 shares in the last quarter. Westfield Capital Management Co. LP grew its stake in Axon Enterprise by 12.2% in the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after purchasing an additional 127,769 shares in the last quarter. Champlain Investment Partners LLC grew its stake in Axon Enterprise by 13.9% in the third quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock valued at $272,695,000 after purchasing an additional 83,265 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in Axon Enterprise by 1.6% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock valued at $224,281,000 after purchasing an additional 9,090 shares in the last quarter. Finally, Groupama Asset Managment purchased a new position in Axon Enterprise in the third quarter valued at about $200,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have recently issued reports on AXON. Northcoast Research downgraded Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. The Goldman Sachs Group upped their price target on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research note on Monday, January 27th. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. JMP Securities reiterated an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Finally, Needham & Company LLC upped their price target on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. Three analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $561.31.

Insider Buying and Selling at Axon Enterprise

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Jeffrey C. Kunins sold 1,035 shares of the stock in a transaction that occurred on Monday, December 23rd. The stock was sold at an average price of $624.47, for a total value of $646,326.45. Following the sale, the insider now owns 124,243 shares in the company, valued at approximately $77,586,026.21. This trade represents a 0.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 8,711 shares of company stock valued at $5,631,561 in the last quarter. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Trading Down 2.6 %

Axon Enterprise stock opened at $499.73 on Tuesday. The business has a 50 day moving average price of $616.95 and a two-hundred day moving average price of $520.78. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The stock has a market cap of $38.11 billion, a price-to-earnings ratio of 129.13, a price-to-earnings-growth ratio of 5.43 and a beta of 1.05. Axon Enterprise, Inc. has a 12 month low of $265.32 and a 12 month high of $715.99.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.